Close

News

Kodiak begins three phase 3 studies of anti-VEGF antibody biopolymer conjugate, KSI-301 to treat DME and macular edema due to retinal vein occlusion

Kodiak Sciences Inc., a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced that the first patients have been treated in the randomized, double-masked GLEAM, GLIMMER and BEACON studies, three pivotal...

Blue Dart strengthens temperature controlled logistics solution to fight against COVID-19

Blue Dart, India’s leading express logistics service provider and part of the Deutsche Post DHL Group (DPDHL) with its commitment to help improve the supply chain and ensure timely medical provisions is ramping up its infrastructure with its pre-existing...

Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis

Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for SB11, a proposed biosimilar referencing Lucentis® (ranibizumab). Ranibizumab is an anti-VEGF (vascular endothelial growth factor) for...

Gilead takes over distribution of Covid-19 antiviral drug from federal government

The maker of the first antiviral drug to get authorization from regulators for Covid-19 anticipates meeting real-time demand for it around the world this month and is already meeting demand in the U.S. Foster City, California-based Gilead Sciences said Thursday...

DuPont to Virtually Showcase Technical Expertise and Commitment to Pharmaceutical Customers at CPhI: Festival of Pharma

DuPont announced it will participate in the virtual CPhI: Festival of Pharma, highlighting its commitment to meet customers’ needs for essential innovations to address the challenges of the COVID-19 global pandemic. DuPont’s technical leaders will draw upon their decades of...

Dr. Reddy’s Laboratories Goes Paperless in Validation with ValGenesis VLMS

ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), announced that it has digitized the validation process at Dr. Reddy's Laboratories across multiple sites, driven by ValGenesis VLMS – the industry's most trusted electronic validation lifecycle...

Cobra Biologics selected to manufacture plasmids for clinical trial of Scancell’s COVID-19 vaccine

Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO manufacturer of biological materials and pharmaceuticals, and Scancell Holdings plc (Scancell), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announced that they...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »